February - University of Toronto's Undergraduate Pharmacy Society
February - University of Toronto's Undergraduate Pharmacy Society
February - University of Toronto's Undergraduate Pharmacy Society
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Reviewing the Human Papillomavirus Vaccine<br />
Program and the Role <strong>of</strong> the Pharmacist<br />
By: Be Phan - 1T0 (3rd Place, CAPSI Student Literary Challenge)<br />
~ I would like to thank T.K. for all her guidance and support. Thank<br />
you for everything!<br />
Introduction<br />
In July 2006, Health Canada approved a new Human Papillomavirus<br />
(HPV) vaccine, Gardasil, manufactured by Merck & Co. 7 The approval<br />
<strong>of</strong> Gardasil and its recommendation for use in a national HPV<br />
vaccination program has raised both excitement and concern from<br />
Canadian health pr<strong>of</strong>essionals and the public. As trusted health care<br />
providers, pharmacists must take an active role in understanding the<br />
facts surrounding the introduction <strong>of</strong> the vaccine in order to properly<br />
address the concerns <strong>of</strong> the public. This article shall briefly outline the<br />
main facts about HPV, discuss the introduction <strong>of</strong> the HPV vaccine into<br />
a publicly funded immunization program, and explore the potential for<br />
pharmacists to play a critical role in the program.<br />
The Human Papillomavirus<br />
HPV is one <strong>of</strong> the most common sexually transmitted infections<br />
in Canada. 6 The HPV family consists <strong>of</strong> over 100 viruses and are<br />
transmitted through skin contact. 2 There are about 40 genotypes that<br />
can infect the genital tract. Estimates <strong>of</strong> the overall prevalence <strong>of</strong><br />
any type <strong>of</strong> HPV, in Canada, ranges from 10.8% to 29.0%. 6 The peak<br />
prevalence occurs in young adults (